Cargando…

Early Predictive Response to Multi-Tyrosine Kinase Inhibitors in Advanced Refractory Radioactive-Iodine Differentiated Thyroid Cancer: A New Challenge for [(18)F]FDG PET/CT

Differentiated thyroid cancer (DTC) represents the most common thyroid cancer histotype. Generally, it exhibits a good prognosis after conventional treatments; nevertheless, about 20% of patients can develop a local recurrence and/or distant metastasis. In one-third of advanced DTC, the metastatic l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferrari, Cristina, Santo, Giulia, Ruta, Rossella, Lavelli, Valentina, Rubini, Dino, Mammucci, Paolo, Sardaro, Angela, Rubini, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392185/ https://www.ncbi.nlm.nih.gov/pubmed/34441351 http://dx.doi.org/10.3390/diagnostics11081417

Ejemplares similares

[(18)F]Fluciclovine PET/CT Improves the Clinical Management of Early Recurrence Prostate Cancer Patients
por: Nappi, Anna Giulia, et al.
Publicado: (2022)

[(18)F]FDG PET/CT in head and neck squamous cell carcinoma: a head-to-head between visual point-scales and the added value of multi-modality imaging
por: Ferrari, Cristina, et al.
Publicado: (2023)

Comparison of the Diagnostic Value of MRI and Whole Body (18)F-FDG PET/CT in Diagnosis of Spondylodiscitis
por: Altini, Corinna, et al.
Publicado: (2020)

Usefulness of (18)F-FDG PET/CT in Patients with Cardiac Implantable Electronic Device Suspected of Late Infection
por: Rubini, Giuseppe, et al.
Publicado: (2020)

[(18)F]fluciclovine vs. [(18)F]fluorocholine Positron Emission Tomography/Computed Tomography: A Head-to-Head Comparison for Early Detection of Biochemical Recurrence in Prostate Cancer Patients
por: Ferrari, Cristina, et al.
Publicado: (2022)

Lesion-to-Liver SUVmax Ratio to Improve the Prognostic Value of the End of Treatment PET/CT in Diffuse Large B-Cell Lymphoma
por: Ferrari, Cristina, et al.
Publicado: (2022)

(18)F-Fluorocholine PET/CT, Tc-99m-MIBI and TC-99m-MDP SPECT/CT in Tertiary Hyperparathyroidism with Renal Osteodystrophy
por: Ferrari, Cristina, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors in Advanced NSCLC: [(18)F]FDG PET/CT as a Troubleshooter in Treatment Response
por: Ferrari, Cristina, et al.
Publicado: (2021)

Intracranial Solitary Fibrous Tumor: A “New” Challenge for PET Radiopharmaceuticals
por: Sardaro, Angela, et al.
Publicado: (2022)

Diagnostic Value of Choline PET in the Preoperative Localization of Hyperfunctioning Parathyroid Gland(s): A Comprehensive Overview
por: Ferrari, Cristina, et al.
Publicado: (2021)

Clinical role of (18)F-FDG PET/CT for detection of radioactive iodine refractory differentiated thyroid cancer
por: Tang, Xiaowei, et al.
Publicado: (2023)

Heterogeneous Response to Immunotherapy in a Patient with Tonsillar Squamous Cell Carcinoma Assessed by (18)F-FDG PET/CT
por: Niccoli Asabella, Artor, et al.
Publicado: (2021)

The Day after Mass COVID-19 Vaccination: Higher Hypermetabolic Lymphadenopathy Detection on PET/CT and Impact on Oncologic Patients Management
por: Ferrari, Cristina, et al.
Publicado: (2021)

Early Evaluation of Immunotherapy Response in Lymphoma Patients by 18F-FDG PET/CT: A Literature Overview
por: Ferrari, Cristina, et al.
Publicado: (2021)

Tyrosine-Kinase Inhibitors Therapies with Mainly Anti-Angiogenic Activity in Advanced Renal Cell Carcinoma: Value of PET/CT in Response Evaluation
por: Ranieri, Girolamo, et al.
Publicado: (2017)

(18)F-FDG PET/CT Role in Staging of Gastric Carcinomas: Comparison with Conventional Contrast Enhancement Computed Tomography
por: Altini, Corinna, et al.
Publicado: (2015)

Lympho-SPECT/CT as a Key Tool in the Management of a Patient with Chylous Ascites
por: Iuele, Francesca, et al.
Publicado: (2023)

Prospective Analysis of (18)F-FDG PET/CT Predictive Value in Patients with Low Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy and Conservative Surgery
por: Niccoli-Asabella, Artor, et al.
Publicado: (2014)

Pediatric Hodgkin Lymphoma: Predictive value of interim (18)F-FDG PET/CT in therapy response assessment
por: Ferrari, Cristina, et al.
Publicado: (2017)

Using 18F-FDG-PET/CT Metrics to Predict Survival in Ra-Dio-Iodine Refractory Thyroid Cancers
por: Roy, Malanie, et al.
Publicado: (2022)

Impact of 18F-FDG PET/CT on Clinical Management of Suspected Radio-Iodine Refractory Differentiated Thyroid Cancer (RAI-R-DTC)
por: Lodi Rizzini, Elisa, et al.
Publicado: (2021)

State of the art of (18)F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation
por: Casali, Massimiliano, et al.
Publicado: (2021)

A Rare Case of Primary Uterine Non-Hodgkins's Lymphoma with Involvement of Right Ovary: Staging with 18F FDG PET/CT and Iodinated Contrast CT
por: Lamacchia, Feliciana, et al.
Publicado: (2019)

The Lymphoscintigraphic Study of Unpredictable Head and Neck Cutaneous Melanoma Lymphatic Drainage
por: Lavelli, Valentina, et al.
Publicado: (2020)

Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis
por: Wang, Chen, et al.
Publicado: (2017)

Identification of Radioactive Iodine Refractory Differentiated Thyroid Cancer
por: Mu, Zhuan-Zhuan, et al.
Publicado: (2019)

(18)F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study
por: Farina, Eleonora, et al.
Publicado: (2017)

(18)F-FDG-PET/CT in Patients with Advanced, Radioiodine Refractory Thyroid Cancer Treated with Lenvatinib
por: Ahmaddy, Freba, et al.
Publicado: (2021)

(68)Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with (177)Lu-PSMA-617
por: de Vries, Lisa H., et al.
Publicado: (2020)

(18)F-FDG PET/CT Imaging In Oncology
por: Almuhaideb, Ahmad, et al.
Publicado: (2011)

Scar Sarcoidosis on (18)F-FDG PET/CT
por: Arora, Saurabh, et al.
Publicado: (2019)

18F-FDG PET/CT and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

Renal dysfunction in patients with radioactive iodine-refractory thyroid cancer treated with tyrosine kinase inhibitors: A retrospective study
por: Iwasaki, Hiroyuki, et al.
Publicado: (2019)

Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
por: Liu, Jierui, et al.
Publicado: (2019)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors
por: Evangelista, Laura, et al.
Publicado: (2023)

Crossed cerebellar diaschisis on F-18 FDG PET/CT
por: Agrawal, Kanhaiya Lal, et al.
Publicado: (2011)

Peritoneal Mouse as Detected on (18)F-FDG PET-CT
por: Allam, Talha, et al.
Publicado: (2013)

Staging recurrent ovarian cancer with (18)FDG PET/CT
por: DRAGOSAVAC, SANJA, et al.
Publicado: (2013)

Dialysis Related Amyloid Arthropathy on (18)FDG PET-CT
por: Kecler-Pietrzyk, A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tv832sj4r4viqgm10pcolis9tr